Sanofi-Aventis Vietnam Ltd. has recently organised a ceremony to celebrate the first batch of pharmaceutical import in Ho Chi Minh City.
|Sanofi is the first lawful multinational importer in the pharmaceutical industry in Vietnam |
Sanofi-Aventis Vietnam Ltd. has received an import license for pharmaceutical trading in Vietnam, pursuant to the Ministry of Health’s Decision No.2542/QD-BYT and Decree No.54/2017/ND-CP dated May 8, 2017, issued by the government. This accreditation turns Sanofi into the first lawful multinational importer in the drug production industry in the country.
The licence is expected to bring about a new window of opportunity for growth and enable the company to increase its contribution to the local community healthcare landscape, since being granted the license indicates that Sanofi is capable of satisfying all relevant statutory, quality, and technical requirements and regulations.
Sanofi Vietnam aims at providing patients with high-quality medicinal products researched and developed by Sanofi and sourced from its domestic TGA, WHO-GMP (Good Manufacturing Practices) factories and other sister facilities in its global production network.
The supply chain plays a crucial role in this business goal. After becoming a recognised importer, Sanofi can now simplify its supply chain and provide higher quality products thanks to a well-stabilised supply and enhanced storage and transportation practices.
“It is our delight to welcome the very first batch of direct medicinal import. The batch is packed with the latest innovative vaccination solutions intended to prevent infection caused by Neisseria meningitides, chesty cough syrup for children, and venous thromboembolic treatment medicines,” said Haissam Chraiteh, Sanofi Indochina general director. “By directly importing prescription, OTC, and vaccination products, Sanofi has successfully fulfilled a long-term commitment as a trusted partner to empower Vietnamese people’s life.”
Sanofi has also inaugurated a GSP-standard drug warehouse facility in District 9, Ho Chi Minh City, which will be utilised to accommodate imported batches from overseas. The facility consists of two storage zones and strictly complies with global drug preservation standards, including temperature (ranging from 2-8 to 20-24 degrees Celcius), good security, and convenient location for domestic transport operations.
Vietnam has recently been recognised as a Pharmerging nation as healthcare demands are soaring directly proportional to factors such as enhanced living standards, population ageing, and per-capita income on the rise. It is a positive signal for local communites when multinational R&D-based powerhouses like Sanofi begin to be recognised as an importer of pharmaceutical products. Consequently, people are gaining more exposure to innovative and cutting edge solutions while Vietnam is getting closer to regional healthcare standards.